ZYN002 Transdermal Gel Cannabidiol (CBD), ZYN002 Placebo Transdermal Gel clinical trials

A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents, and Young Adults with Fragile X Syndrome - RECONNECT

This study is testing a CBD gel called ZYN002 for people with Fragile X syndrome. It aims to see if the gel can help with social avoidance and other behaviours in children, teenagers, and young adults.